| ¿µ¹® | edema | ÇÑ±Û | ºÎÁ¾ |
|---|---|---|---|
| ¼³¸í | Á¶Á÷³»¿¡ ¸²ÇÁ¾×À̳ª Á¶Á÷ÀÇ »ïÃâ¹° µîÀÇ ¾×ü°¡ Àú·ùµÇ¾î¼ °úÀ× Á¸ÀçÇÏ´Â »óŸ¦ ¸»ÇÑ´Ù. ÀÌ·± Çö»óÀº »ý±â´Â ºÎÀ§¿¡ µû¶ó ÇÇÇϺÎÁ¾, ÆóºÎÁ¾, º¹¼ö¶ó Çϸç, ¹ß»ý ±âÀü¿¡ µû¶ó ºÐ·ùÇÏ¸é ¿ïÇ÷¼º ºÎÁ¾, ¿°Áõ¼º ºÎÁ¾, Ç÷°ü¿îµ¿¼º ºÎÁ¾, ±â¾Æ¼º ºÎÁ¾, ÄáÆÏÅ¿ ºÎÁ¾ µîÀ¸·Î ºÐ·ùµÈ´Ù. ¿ïÇ÷¼º ºÎÁ¾Àº ±â´É¼º ºÎÁ¾À̶ó°íµµ Çϸç, Á¤¸ÆÀ̳ª ¸²ÇÁ°üÀÇ ÇùÂø, Æó¼â·Î ÀÎÇÏ¿© Á¤»óÀûÀÎ È帧ÀÌ ¹æÇع޾ÒÀ» ¶§¿¡ ¹ß»ýÇÏ´Â °ÍÀÌ´Ù. ¿°Áõ¼º ºÎÁ¾Àº ¿°Áõ¼º º¯È·Î ÀÎÇØ¼ Ç÷°üÀÇ Åõ°ú¼ºÀÌ Ç×ÁøµÇ¾î Ç÷°ü¼Ó¿¡ ÀÖ´Â ¼öºÐÀÌ ¸¹ÀÌ Á¶Á÷À¸·Î ºüÁ® ³ª°¡¼ »ý±â´Â ºÎÁ¾À̰í, Ç÷°ü¿îµ¿¼º ºÎÁ¾Àº Ç÷°ü¿îµ¿½Å°æ ¸¶ºñ·Î À¯¹ßµÇ¸ç, ±â¾Æ¼º ºÎÁ¾Àº ¸¸¼ºÀûÀ¸·Î ¿µ¾çÀÌ ºÎÁ·ÇÑ °æ¿ì¿¡ »ý±â´Â ºÎÁ¾ÀÌ´Ù. ÄáÆÏÅ¿ ºÎÁ¾Àº ÄáÆÏº´ÀÌ ÀÖ´Â °æ¿ì¿¡ ¼Òº¯À¸·Î ¿µ¾çºÐÀÌ ºüÁ®³ª°¡´Â °æ¿ì¿¡ À¯¹ßµÈ´Ù. ºÎÁ¾Àº »ý±â´Â ºÎÀ§¿¡ µû¶ó ´Ù¼Ò Â÷À̰¡ ÀÖÀ»Áö¶óµµ ¹ß»ý±âÀü¿¡¼´Â ¼·Î ¹ÐÁ¢ÇÑ °ü·ÃÀ» ¸Î°í ÀÖÀ¸¹Ç·Î ±Ùº»ÀûÀÎ ¿øÀÎÀ» ã¾Æ³»¾î Ä¡·á¸¦ ½ÃÀÛÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù. |
||
| ¿µ¹® | renal biopsy | ÇÑ±Û | ÄáÆÏ»ý°Ë |
|---|---|---|---|
| ¼³¸í | ÄáÆÏÀÇ º´º¯ÀÌ ÀÇ½ÉµÉ ¶§ È®ÁøÀ» À§ÇØ ÁÖ»ç¹Ù´Ã µîÀ» ÀÌ¿ëÇÏ¿© ÄáÆÏÁ¶Á÷À» ÀϺΠ¶¼¾î³»¼ Çö¹Ì°æÀ¸·Î °Ë°æÇÏ´Â °Í. |
||
| ¿µ¹® | renal hypertension | ÇÑ±Û | ÄáÆÏ¼º°íÇ÷¾Ð |
|---|---|---|---|
| ¼³¸í | ÄáÆÏ½ÇÁúÀÇ º´º¯À¸·Î ÀÎÇØ ¾ß±âµÈ °íÇ÷¾Ð. ÄáÆÏÀÇ ´ëÇ¥Àû ±â´ÉÀº ³ëÆó¹° ¹× ¼öºÐÀÇ ¹è¼³ÀÌ´Ù. ±×·±µ¥ ÀÌ·¯ÇÑ ÄáÆÏ±â´É¿¡ ÀÌ»óÀÌ »ý°åÀ» °æ¿ì ü³»¿¡ °úÀ×¼öºÐÀÇ ÃàÀûÀÌ ¹ß»ýÇÏ°Ô µÈ´Ù. À̿Ͱ°Àº °úÀ×¼öºÐÀÇ ÃàÀûÀº Ç÷°ü³» Á¤¼ö¾ÐÀ» »ó½Â½ÃÄÑ °íÇ÷¾ÐÀ» À¯¹ßÇÏ°Ô µÈ´Ù. Ä¡·á´Â ¿øÀÎ ÄáÆÏº´ÀÇ ±³Á¤À̸ç ÀÌÀ¯¸¦ ¸ð¸£´Â ¿ø¹ß°íÇ÷¾Ð°ú ´Þ¸® ÄáÆÏ¼º°íÇ÷¾ÐÀÇ °æ¿ì¿¡´Â ¿øÀÎ ÄáÆÏº´ÀÌ ±³Á¤µÇ¸é °íÇ÷¾Ðµµ »ç¶óÁö°Ô µÈ´Ù. |
||
| ¿µ¹® | renal cell carcinoma | ÇÑ±Û | ÄáÆÏ¼¼Æ÷¾ÏÁ¾ |
|---|---|---|---|
| ¼³¸í | ÄáÆÏ¿¡ »ý±ä ¿ø½ÃÄáÆÏÁ¶Á÷¿¡¼ ¹ß»ýÇÑ ¾Ï. ÁÖ·Î ¿ø½Ã¼¼´¢°üÁ¶Á÷¿¡¼ ¹ß»ýÇÑ´Ù. ´ëÇ¥ÀûÀÎ ¼¼Æ÷Á¶Á÷ÇüÀº ¿°»ö½Ã ¼¼Æ÷ÁúÀÌ ¸¼°Ô ºñ¾îº¸ÀÌ´Â ¸¼Àº¼¼Æ÷¾ÏÁ¾ÀÌ´Ù. Ä¡·á´Â ¼ö¼ú°ú Ç×¾ÏÈÇпä¹ýÀÌ¸ç ¾ÆÁÖ µå¹°Áö¸¸ ÀúÀý·Î ³´´Â °æ¿ìµµ ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | renal transplantation | ÇÑ±Û | ÄáÆÏÀÌ½Ä |
|---|---|---|---|
| ¼³¸í | ÄáÆÏº´À» °¡Áö°í ÀÖÀ¸³ª Ä¡·á°¡ ºÒ°¡´ÉÇÑ ¸¸¼ºÄáÆÏ±â´É»ó½Ç µîÀÇ Áúº´À» °¡Áø ȯÀÚÀÇ ½ÅÀåÀ» ¶¼¾î³»°í ȯÀÚ¿Í Ç׿ø¼ºÀÌ À¯»çÇÑ »ç¶÷ÀÇ ÄáÆÏÀ» À̽ÄÇØÁÖ´Â °Í. ÀÌ ¶§ ¼·Î°£ÀÇ Ç׿ø¼ºÀÇ À¯»çÁ¡ÀÌ ¸¹¾Æ¾ß °ÅºÎ¹ÝÀÀÀÌ ÀϾÁö ¾Ê´Â´Ù. ±×¸®°í ÀÏ´Ü ÄáÆÏÀ̽ÄÀ» ¹ÞÀº »ç¶÷Àº ¿À·£±â°£ µ¿¾È ¸é¿ª¾ïÁ¦Á¦¸¦ Åõ¿©ÇÏ¿© °ÅºÎ¹ÝÀÀÀ» ÁÙ¿©¾ß ÇÑ´Ù. ´ë°³ ÀÌ½ÄµÈ ÄáÆÏÀº ¾ûµ¢»À¿À¸ñ¿¡ À§Ä¡ÇÏ°Ô µÈ´Ù. |
||
| HPE | hepatic portoenterostomy; high-permeability edema; history and physical examination; holoprosencepha... |
|---|---|
| CRD | carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint... |
| CRT | cadaveric renal transplant; cardiac resuscitation team; cathode-ray tube; certified; Certified Recor... |
| RVRA | renal vein rein activity; renal venous renin assay |
| SRF | severe renal failure; skin reactive factor; somatotropin-releasing factor; split renal function; sub... |
| BE | Brain edema |
|---|---|
| CSME | Clinically significant macular edema |
| CME | Cystoid macular edema |
| EPH | Edema Proteinuria Hypertension |
| HANE | Hereditary Angio Neurotic Edema |
| edema | <clinical sign> The presence of abnormally large amounts of fluid in the intercellular tissue spaces of the body, usually applied to demonstrable accumulation of excessive fluid in the subcutaneous tissues. Oedema may be localised, due to venous or lymphatic obstruction or to increased vascular permeability or it may be systemic due to heart failure or renal disease. Collections of oedema fluid are designated according to the site, for example ascites (peritoneal cavity), hydrothorax (pleural cavity) and hydropericardium (pericardial sac). Massive generalised oedema is called anasarca. Origin: Gr. Oide ma = swelling (18 Nov 1997) |
|---|---|
| edema, cardiac | A manifestation of congestive heart failure caused by increased venous and capillary pressures and often associated with the retention of sodium by the kidneys. (12 Dec 1998) |
| acute renal failure | <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes. Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect). Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement. (27 Sep 1997) |
| aminoaciduria, renal | Impairment of renal tubular transport of amino acids. (12 Dec 1998) |
| back-pressure renal atrophy | <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids (12 Dec 1998) |
| base of renal pyramid | The outer broad part of a renal pyramid that lies next to the cortex. Synonym: basis pyramidis renis. (05 Mar 2000) |
| branchio-oto-renal syndrome | <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation. (12 Dec 1998) |
| capsular branches of renal artery | <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule. Synonym: rami capsulares arteriae renalis. (05 Mar 2000) |
| captopril renal scan | <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis (12 Dec 1998) |
| carcinoma, renal cell | Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural. (12 Dec 1998) |
| renal | <anatomy> Pertaining to the kidney, nephric. (18 Nov 1997) |
| renal adenocarcinoma | <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging (12 Dec 1998) |
| renal adenocarcinoma: staging | <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs (12 Dec 1998) |
| renal adenocarcinoma: vascularity | <radiology> 85% hypervascular (require pre-op embolization), 10% hypovascular (usually the papillary type), 5% avascular also: 10% are bilateral (12 Dec 1998) |
| renal agenesis | <radiology> Associated with, duplicated vagina and/or uterus (mullerian duct anomaly), seminal vesicle cysts (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|